Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- Check6 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No study content or functionality is altered.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the previous notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page adds a government funding/status notice and updates to revision v3.4.1, while removing the previous v3.4.0 revision.SummaryDifference0.4%

- Check48 days agoChange DetectedMinor UI and metadata changes: a glossary toggle was added and the footer now displays 'Last Update Submitted that Met QC Criteria' with revision 'v3.4.0', while the previous label 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3. This appears to be a minor version update with no observable changes to study content, eligibility criteria, or results.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with California sites; removed the California Locations and HHS Vulnerability Disclosure links; updated the footer revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.